Lexpos News

/Lexpos News

NHS’ Sexual Safety Charter

NHS England has tasked Integrated Care Boards (ICBs) to encourage primary care providers, including community pharmacies, to sign up to the NHS Sexual Safety Charter. All employers in the UK have a legal duty to take reasonable steps to prevent sexual harassment in the workplace. The sexual safety of staff and patients is an essential [...]

The post NHS’ Sexual Safety Charter appeared first on Community Pharmacy England.

By |January 23rd, 2026|Lexpos News|Comments Off on NHS’ Sexual Safety Charter

CPE pushes Minister for roadmap to recovery ahead of make-or-break negotiations

Community pharmacies across the country have entered 2026 “in real economic peril” and urgently need a roadmap to recovery, Community Pharmacy England has warned the Government ahead of upcoming negotiations. In an uncompromising letter to Pharmacy Minister Stephen Kinnock, CEO Janet Morrison has outlined the sector’s escalating crisis and called on Government to deliver rapid [...]

The post CPE pushes Minister for roadmap to recovery ahead of make-or-break negotiations appeared first on Community Pharmacy England.

By |January 23rd, 2026|Lexpos News|Comments Off on CPE pushes Minister for roadmap to recovery ahead of make-or-break negotiations

January 2026 Price Concessions 2nd Update

The Department of Health and Social Care (DHSC) has today (23/01/2026) confirmed the following list of price concessions for January 2026: Drug Pack size Price concession Alfuzosin 2.5mg tablets 60 £6.54 Aspirin 75mg gastro-resistant tablets 28 £1.00 Clomipramine 50mg capsules 28 £6.89 Cyclizine 50mg/1ml solution for injection ampoules 5 £3.59 Duloxetine 60mg gastro-resistant capsules 28 [...]

The post January 2026 Price Concessions 2nd Update appeared first on Community Pharmacy England.

By |January 23rd, 2026|Lexpos News|Comments Off on January 2026 Price Concessions 2nd Update

MHRA Drug Safety Update: Isotretinoin – changes to prescribing guidance and additional risk minimisation measures

The Commission on Human Medicines (CHM) has endorsed changes to the risk minimisation measures for isotretinoin, following a review of the impact of the measures implemented in 2023. We ask healthcare professionals to review these new measures and supporting materials and integrate them into their clinical practice. Second prescriber no longer required plus updated risk [...]

The post MHRA Drug Safety Update: Isotretinoin – changes to prescribing guidance and additional risk minimisation measures appeared first on Community Pharmacy England.

By |January 22nd, 2026|Lexpos News|Comments Off on MHRA Drug Safety Update: Isotretinoin – changes to prescribing guidance and additional risk minimisation measures

Expiry of SSP084 Adipine® XL 30mg MR tablets and SSP085 Adipine® XL 60mg MR tablets

The Department of Health and Social Care (DHSC) has confirmed that the Serious Shortage Protocols (SSP) for Adipine® XL 30mg MR tablets (SSP084) and Adipine® XL 60mg MR tablets (SPP085) will expire at 23:59pm Friday 23rd January 2026. SSP 084 and SSP085 were originally set to expire on 6th February 2026 however, the expiry has been [...]

The post Expiry of SSP084 Adipine® XL 30mg MR tablets and SSP085 Adipine® XL 60mg MR tablets appeared first on Community Pharmacy England.

By |January 22nd, 2026|Lexpos News|Comments Off on Expiry of SSP084 Adipine® XL 30mg MR tablets and SSP085 Adipine® XL 60mg MR tablets